Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy
Journal of Comparative Effectiveness Research · 2025
DOI: 10.57264/cer-2024-0208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von David Garcia und 5 weiteren Autor:innen. Beteiligte Einrichtung: EVERSANA, 3228 South Service Road, Burlington, Ontario, Canada, L7N 3H8. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Point-of-Care Testing, Budgets, Dyslipidemias. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
Screening and monitoring of diabetes or dyslipidemia frequently involves a multi-step process requiring patients to obtain test requisitions from their primary care physician (PCP), followed by a laboratory visit and re-consultation. Point-of-care testing (POCT) for hemoglobin A 1c (HbA 1c ) and lipid panel can streamline the patient care pathway. This study assessed the budget impact of introducing Afinion™ 2 POCT (Abbott Rapid Diagnostics) from the Canadian and Italian societal perspectives.
Methods
Budget impact models were developed for Canada and Italy over a 5-year time horizon (2025 to 2029). The analyses considered the screening and monitoring of diabetes or dyslipidemia for patients utilizing the public healthcare system and attending primary care, and included direct costs (testing, consultations) and indirect costs (productivity loss, transportation) based on published sources. The budget impact (BI) was calculated by comparing scenarios with and without POCT. All costs were adjusted to Canadian dollars ($) or 2024 Euros (€). Scenario analyses were conducted to explore the impact of alternative assumptions.
Results
The 5-year cumulative BI was -$758,006,692 (-$50,709,964 direct, -$707,296,728 indirect) for HbA 1c POCT and -$726,452,755 ($2,684,011 direct, -$729,136,766 indirect) for lipid panel POCT in Canada and -€1,380,658,764 (-€6,391,954 direct, -€1,374,266,809 indirect) for HbA 1c POCT and -€851,792,115 (€55,962,879 direct, -€907,754,993 indirect) for lipid panel POCT in Italy. In both countries, cost savings for both the healthcare payer and patients were observed for HbA 1c POCT, while costs savings were derived from patient indirect costs for lipid panel POCT. The analyses estimated that 1,558,062 and 1,501,260 PCP consultations in Canada, 4,962,338 and 1,951,026 PCP consultations in Italy were avoided with implementation of POCT for HbA 1c and lipid panel, respectively. Scenario analyses demonstrated potential further cost savings with implementation of POCT in pharmacies.
Conclusion
This study demonstrates that the adoption of Afinion 2 POCT for HbA 1c and lipid panel can provide efficiencies to different types of healthcare systems through reducing PCP consultations, saving time and money for patients and providing cost savings for payers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- EVERSANA, 3228 South Service Road, Burlington, Ontario, Canada, L7N 3H8.
- Abbott Rapid Diagnostics, 30 Schanzenstr, Köln, Germany, 51063.
- Abbott Rapid Diagnostics, 185 Corkstown Road, Ottawa, Ontario, Canada, K2H 8V4.
- Abbott Rapid Diagnostics, 110 Viale Thomas Alva Edison, Sesto San Giovanni, MI, Italy, 2009.
ORCID-Profile: David Garcia, Alicyia Walczyk Mooradally, Anna Zhou
Zitieren
APA
Garcia, D., Ruffolo, A., Mooradally, A. W., Zhou, A., Lazaridis, E., & Laurelli, B. (2025). Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0208
Vancouver
Garcia D, Ruffolo A, Mooradally AW, Zhou A, Lazaridis E, Laurelli B. Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2024-0208
BibTeX
@article{Garcia2025,
author = {Garcia, David and Ruffolo, Antonio and Mooradally, Alicyia Walczyk and Zhou, Anna and Lazaridis, Emmanuel and Laurelli, Barbara},
title = {Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy},
journal = {Journal of Comparative Effectiveness Research},
year = {2025},
doi = {10.57264/cer-2024-0208}
}
EUVIMED